Canada markets closed

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.1993-0.0046 (-2.26%)
At close: 04:00PM EDT
0.2051 +0.01 (+2.91%)
After hours: 07:22PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
0
0
0
37
869
Operating Expenses
Research Development
11,701
10,712
21,074
90,774
68,647
Selling General and Administrative
14,362
13,825
11,052
11,284
8,781
Total Operating Expenses
26,063
24,537
32,126
102,058
77,428
Operating Income or Loss
-26,063
-24,537
-32,126
-102,021
-76,559
Interest Expense
3,640
5,553
15,097
861
426
Total Other Income/Expenses Net
34,632
-60,769
-1,192
196
401
Income Before Tax
4,929
-90,859
-51,263
-102,686
-76,584
Income Tax Expense
1,072
705
743
444
472
Income from Continuing Operations
3,857
-91,564
-52,006
-103,130
-77,056
Net Income
3,857
-91,564
-52,006
-103,130
-77,056
Net Income available to common shareholders
3,857
-91,564
-52,006
-103,130
-77,056
Basic EPS
-
-0.56
-2.17
-7.10
-7.11
Diluted EPS
-
-0.56
-2.17
-7.10
-7.11
Basic Average Shares
-
163,368
24,010
14,518
8,734
Diluted Average Shares
-
163,368
24,010
14,518
8,734
EBITDA
-
-83,202
-36,005
-101,673
-76,022